InvestorsHub Logo

williamssc

11/16/20 10:17 AM

#333246 RE: roiresearch #333223

I take it as submitted either today or yesterday by the following wording.
"Investigational New Drug (IND) application also to be submitted this week to the FDA. Both these submissions are part of final preparations for the Company’s multinational Phase 2 clinical trial of Brilacidin for COVID-19, which is on track to commence in 2020 upon gaining required approvals".